Luigi Mearini
Papers
2
Total Citations
34
H-Index
2
About
Luigi Mearini is a distinguished urologic surgeon whose research focuses on advancing surgical techniques for renal and prostate cancers and refining biomarker-based diagnostics. His major contributions include pioneering comparative studies of clampless partial nephrectomy, where he demonstrated that robotic-assisted surgery achieves superior margin and complication rates compared to open and laparoscopic approaches—work that has informed modern nephron-sparing protocols. In prostate cancer diagnostics, Mearini has been instrumental in validating the Prostate Health Index (PHI), showing its enhanced accuracy over traditional PSA tests for detecting aggressive disease at radical prostatectomy. His landmark 2016 study on clampless partial nephrectomy, with 25 citations, remains a key reference in urologic oncology. Additionally, his 2015 PHI study, cited 9 times, helped establish p2PSA derivatives as critical tools for reducing unnecessary biopsies. Mearini’s work bridges surgical innovation and precision diagnostics, directly impacting clinical decision-making for thousands of patients worldwide. His research is essential reading for urologists and oncologists seeking evidence-based approaches to kidney and prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2